LDL-c Lowering, Ischemic Stroke, and Small Vessel Disease Brain Imaging Biomarkers: A Mendelian Randomization Study
Non–High-Density Lipoprotein Cholesterol Levels From Childhood to Adulthood and Cardiovascular Disease Events
Genetic Architecture and Clinical Outcomes of Combined Lipid Disturbances
Asymptomatic Intracranial Artery Stenosis/Occlusion in Heterozygous Familial Hypercholesterolemia: Its Frequency and Implications for Cerebrovascular and Cardiovascular Events
Low-Density Lipoprotein Cholesterol, Cardiovascular Disease Risk, and Mortality in China
Inflammation, Cholesterol, Lipoprotein(a), and 30-Year Cardiovascular Outcomes in Women
Independence of Lipoprotein(a) and Low-Density Lipoprotein Cholesterol–Mediated Cardiovascular Risk: A Participant-Level Meta-Analysis
Combined Effects of Air Pollution and Changes in Physical Activity With Cardiovascular Disease in Patients With Dyslipidemia
Lipid‐Lowering Therapy Use When Indicated and Subsequent Ischemic Stroke Severity
Ages at coronary heart disease and death in familial hypercholesterolaemia: a Danish nationwide study spanning 44 years
Impact of diabetes on risk of major adverse cardiovascular events associated with lipoprotein(a) levels in patients with established atherosclerotic cardiovascular disease
Association of <i>LPA</i> Variants With Risk of Coronary Disease and the Implications for Lipoprotein(a)-Lowering Therapies: A Mendelian Randomization Analysis
Cardiovascular outcomes in adults with low-density lipoprotein cholesterol levels of ≥4.9 mmol/L: 15-year follow-up of the CoLaus|PsyCoLaus study
Lipoprotein(a) and recurrent atherosclerotic cardiovascular events: the US Family Heart Database
Causal Relevance of Lp(a) for Coronary Heart Disease and Stroke Types in East Asian and European Ancestry Populations: A Mendelian Randomization Study
